Equity Research

Myles Minter Quoted in MedCity News

William Blair research analyst Myles Minter’s note on the swift FDA approval of Alzheimer’s drug Leqembi was cited in MedCity News.

Our Latest News

Thursday, January 9, 2025

Cboe Global Markets, Inc.: Initiation of Research Coverage

William Blair initiated research coverage of Cboe Global Markets, Inc. (CBOE $190.84), a leading derivatives and securities exchange network that provides trading, clearing, data, and technology solutions to a broad range of market participants globally.
Read more
Wednesday, January 8, 2025

An AI Inflection Point for Insurtech

The technology necessary to deliver cutting-edge AI solutions across the insurance ecosystem appears to have finally arrived—with the potential to spur a new wave of investment and transaction activity.
Read more
Tuesday, January 7, 2025

William Blair Names Stewart Licudi Head of European Investment Banking

William Blair has named Stewart Licudi as the firm’s head of European investment banking. Based in London, Licudi will lead William Blair’s investment banking advisory activity in Europe.
Read more

See more news

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures